Bioprocess Excellence: Process Development for the AI Age
Bioprocess development is one of the most complex and resource-intensive stages in bringing a therapy to market, and yet many teams still rely on fragmented tools and manual workflows that slow them down.
Join Benchling's Jason Boyd, Head of Regulated Labs Strategy, and Dane Pieri, Product Manager, alongside Heather Robison, Senior Director of Pharmaceutical Science at Addition Therapeutics, as we break down the current process development landscape, share how leading biotech teams are modernizing their bioprocess workflows, and demo how Benchling's bioprocess capabilities, now including AI integration, can help teams move faster from cell line development through process optimization.
What you'll learn:
-
An overview of the current process development landscape and key trends shaping bioprocess R&D
-
How Addition adopted Benchling for bioprocess and the impact on their workflows
-
A live demo of Benchling's bioprocess capabilities, including an AI tie-in
-
Practical takeaways for modernizing your own bioprocess development operations
We also have another session available onĀ April 23 | 10 a.m. BST / 11 a.m. CEST
Note: If you are a Benchling customer, be sure to use your work email address. Much of the Benchling Community is only available to customers so this will ensure you receive full access to the platform. Already have an account? Login
Login to the community
No account yet? Create an account
Benchling Employee? Login with SSO
Benchling Employee LoginEnter your E-mail address. We'll send you an e-mail with instructions to reset your password.